Dr. Chen-Guang Yu received his M.D. degree from Anhui Medical College in Anhui Province, China, in 1982. He received a Ph.D. in Pharmacology, from the Shanghai Second Medical University, Shanghai, China, in 1996. He performed a post-doctoral Associate at University of Miami, Miami, from 1998-2000 and was a faculty member (Assistant Scientist/Research Assistant Professor) at University of Florida from 2001 -2005. He joined the Spinal Cord and Brain Injury Research Center (SCoBIRC), University of Kentucky in May of 2005, as a Scientist III. Dr. Yu is currently an Assistant Professor at SCoBIRC in the Department of Anatomy and Neurobiology, University of Kentucky College of Medicine. He is also serving as an Associate Editor-in-Chief for the Frontiers in Biology and a Scientist Reviewer for Neuroscience peer review panel of the 2012 Spinal Cord Injury Research Program (SCIRP) for the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). He is a reviewer for Spinal Cord. Dr. Yu is an expert in gene therapy and pharmacological intervention in spinal cord injury, SCI pain, and signaling pathways in spinal cord injury.
Dr. Chen Yu\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s research interests focus on elucidating pathogenic mechanisms of spinal cord injury and developing novel therapies to attenuate neurodegeneration, autoimmune neuroinflammation, neuropathic pain, and locomotor deficits after contusive and excitotoxic spinal cord injury in both mouse and rat models. Therapeutic strategies include gene transfer, RNAi approaches including siRNA and lentiviral shRNA therapies, and pharmacological interventions for spinal cord injury.